In 2011, Kate, who was both a doctor and a patient, received the devastating diagnosis of terminal cancer. Despite facing such a challenging situation, Kate's unwavering spirit and determination led her to embark on a remarkable journey to a legacy of change. In 2013, she initiated the Hello My Name Is campaign, which has now reached a significant milestone as it celebrates its tenth anniversary this year.
Tragically, Kate passed away in 2016, leaving behind an extraordinary legacy. By that point, her tireless efforts had raised an impressive £250,000 for local charities through various fundraising activities and the publication of two books dedicated for The Leeds Hospital Charity. Her passion and commitment to making a difference were truly inspirational.
Following Kate's untimely departure, her devoted husband Chris Pointon took up the mantle and continued the campaign. Today, Hello My Name Is has expanded its reach to over 20 countries across the globe and has become deeply embedded within the fabric of most of the National Health Service (NHS). Chris's dedication and unwavering commitment have been instrumental in sustaining the campaign's impact and ensuring its continued growth.
Notably, the fundraising efforts in support of two local charities persist under the guidance of Chris and the Hello My Name Is campaign. The campaign has now raised an astounding £525,000 for St Gemma's Hospice and The Leeds Hospital Charity. These funds have undoubtedly made a significant difference in the lives of countless individuals and have contributed to the invaluable work carried out by these organisations.
Kate's legacy lives on through the incredible individuals who are committed to making a positive impact. Each one of you, the nominees and recipients of this prestigious award, embodies the spirit of Kate and her unwavering determination to create change.
Through your remarkable efforts and contributions, you continue to carry forward Kate's vision, ensuring that her legacy remains a beacon of hope and inspiration for all.